Procurement Summary
Country : USA
Summary : FY25 Bulk Pharma Buy (Materiel)
Deadline : 08 Jan 2025
Other Information
Notice Type : Tender
TOT Ref.No.: 112250956
Document Ref. No. : BulkPharmaC-Materiel
Competition : ICB
Financier : Self Financed
Purchaser Ownership : Public
Tender Value : Refer Document
Purchaser's Detail
Name :Login to see tender_details
Address : Login to see tender_details
Email : Login to see tender_details
Login to see detailsTender Details
Description
THIS CORRECTION IS POSTED TO SPECIFY THE RESPONSE SHALL BE NO LONGER THAN FIFTEEN (15) PAGES AND TO CHANGE THE SUBMISSION DATE TO JANUARY 8, 2025.
THIS IS A REQUEST FOR INFORMATION (RFI) ONLY. This RFI is issued solely for information and planning purposes to support market research efforts. It does not constitute a Request for Proposal (RFP), Request for Quotation (RFQ), Invitation for Bids (IFB) or a promise to issue an RFP, RFQ, IFB in the future. The request does not obligate or commit the Government to contract for any supply or service nor does it intend to award a contract on the basis of this RFI. There shall be no basis for claims against the Government as a result of information submitted in response to this RFI. Further, HHS is not seeking a proposal and will not accept any related unsolicited proposals.
Responders are advised that the Government will not pay for any information, or any administrative costs incurred in response to the RFI. All associated costs will be solely at the responding party-s expense. Information and materials provided in response to this RFI will not be returned. Based on the response to this RFI, a determination to compete or not to compete a future procurement is solely within the discretion of the U.S. Government.
SNS is seeking information on vendor-s availability to provide acceptable pharmaceuticals (See RFI Attachment A for quantities information):
Amoxicillin 400mg/5ml oral suspension, powder, 100ml bottle
Ciprofloxacin 250mg/5ml oral suspension, powder, 100ml bottle
Ciprofloxacin soln. for inj., 400mg in D5W 200ml flexi-bag
Clindamycin phosphate, 150mg/cc in 6cc vial
Active Contract Opportunity
Notice ID : BulkPharmaC-Materiel
Related Notice
Department/Ind. Agency : HEALTH AND HUMAN SERVICES, DEPARTMENT OF
Sub-tier : OFFICE OF ASSISTANT SECRETARY FOR PREPAREDNESS AND RESPONSE
Office: ASPR/ORM-SNS
General Information
Contract Opportunity Type: Sources Sought (Updated)
Updated Published Date: Dec 23, 2024 07:46 am EST
Original Published Date: Dec 20, 2024 03:31 pm EST
Updated Response Date: Jan 08, 2025 04:00 pm EST
Original Response Date: Jan 09, 2025 04:00 pm EST
Inactive Policy: 15 days after response date
Updated Inactive Date: Jan 23, 2025
Original Inactive Date: Jan 24, 2025
Initiative: None
Classification
Original Set Aside:
Product Service Code: 6505 - DRUGS AND BIOLOGICALS
NAICS Code: 325412 - Pharmaceutical Preparation Manufacturing
Place of Performance: Atlanta, GA USA
Documents
Tender Notice